Short answer
Orthofix Medical Inc. (OFIX) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Item 2.02 covers OFIX earnings disclosure; actual results (revenue, EPS, EBITDA figures) are in the accompanying press release exhibit, not this section.
Orthofix Medical Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 covers OFIX earnings disclosure; actual results (revenue, EPS, EBITDA figures) are in the accompanying press release exhibit, not this section
- Non-GAAP framework excludes share-based comp, SeaSpine merger integration costs, M6 disc product line restructuring/impairments, and acquired intangible amortization
- Long-term normalized tax rate set at 28% for 2024–2025 adjusted results: actual GAAP tax may diverge materially
- Adjusted EBITDA is primary metric used by chief operating decision maker: most relevant figure for management performance evaluation and peer comparison
- SeaSpine merger (closed Jan 2023) and M6 disc discontinuation remain active non-GAAP exclusion items: signals ongoing integration/restructuring drag on GAAP earnings
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation (Exhibit 99.2) to be used in analyst/investor meetings throughout fiscal year 2025
- Presentation may be modified over time: signals management actively refining its equity story for current market conditions
- Key substance in Exhibit 99.2; investors should review that document directly for strategic priorities and financial targets
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Orthofix Medical Inc. 8-K filings
Get the next OFIX 8-K as it lands
Follow OFIX for push alerts, or ask the research agent what this filing means.